Document:

Exhibit 10.24

 

AGREEMENT

 

This
Agreement (“Agreement”) is entered into by and between Sandesh Seth (“Director” or “you”) and Relmada
Therapeutics, Inc. (the “Company” or “Relmada”), and confirms the agreement that has been reached with you
in connection with your resignation as a director of the Company (together, the “Parties”).

 

1.    Director
Resignation.    Based on discussions with the board of directors (the “Board”) of the Company
about your intent to focus your attention on matters external to Relmada, you and the Board mutually agree that your resignation
shall be effective as of June 6, 2017 (the “Resignation Date”) and as of such date you shall cease to be Chairman of
the Board and a member of the Board of the Company (as well as of the Board of Directors of any of the Company’s subsidiaries).

 

2.    Consulting
Arrangement.     The Company agrees to continue its advisory and consulting arrangement with you pursuant
to the terms of the Advisory and Consulting Agreement, dated August 4, 2015 (the “Consulting Agreement”), between you
and the Company (subject to the terms and conditions set forth in this Agreement) until December 31, 2017; provided, however, that
this Agreement nullifies the 90-day termination provision of Section 9 of the Consulting Agreement. The Company shall also within
5 days of the Resignation Date pay to you in a lump sum the amount payable to you pursuant to the terms of the Consulting Agreement
from the Resignation Date to December 31, 2017 in addition to any accrued but unpaid fees or expenses through the Resignation Date.

 

3.    Options/Warrants.    Each
of your outstanding options to acquire Company common stock shall be 100% vested upon the Resignation Date and shall be exercisable
until the end of the term of each option grant agreement.

 

4.    Indemnification.
The Company agrees that you will continue to be entitled to any and all rights to contribution, advancement of expenses, defense
or indemnification you may have under the Indemnification Agreement, dated August 10, 2015 (the “Indemnification Agreement”)
attached as Annex A, the indemnification provisions of the agreements and Company documents also listed in Annex A.
The agreements entered into by and between the Company and you and the indemnification sections of the other agreements shall remain
in full force and effect and shall not limit any greater rights provided and/or available to you by any Directors and Officers
liability insurance policy, applicable documents or as a matter of law.

 

5.    No
Other Payments or Benefits.    You acknowledge and agree that, subject to Section 2 of this Agreement,
other than the payments and benefits expressly set forth in this Agreement, you have received all compensation to which you are
entitled from the Company, and you are not entitled to any other payments or benefits from the Company. The Company also agrees
to directly pay to counsel of your choosing the legal expenses you incur in connection with (a) this Agreement, and (b) the Company’s
settlement agreement with Laidlaw & Company (UK) Ltd.

 

6.    Nondisparagement.    The
Parties agree that each Party, will not, with intent to damage, disparage or encourage or induce others to disparage the other
Party, including, as it relates to the Company, the Company’s subsidiaries and affiliates, together with all of their respective
past and present directors and officers and each of their successors and assigns (collectively, the “Company Entities and
Persons”). Nothing in this Agreement is intended to or shall prevent you or the Company from providing, or limiting testimony
in response to a valid subpoena, court order, regulatory request or other judicial, administrative or legal process or otherwise
as required by law. The Parties each agree that each Party will notify the other Party in writing as promptly as practicable after
receiving any request for testimony or information in response to a subpoena, court order, regulatory request or other judicial,
administrative or legal process or otherwise as required by law, regarding the anticipated testimony or information to be provided
and at least ten (10) days prior to providing such testimony or information (or, if such notice is not possible under the
circumstances, with as much prior notice as is possible).

 

7.    Cooperation.    Prior
to and after the Resignation Date, you agree that you will reasonably cooperate with the Company, its subsidiaries and affiliates,
at any level, and any of their officers and directors, shareholders (A) concerning requests for information about the business
of the Company or its subsidiaries or affiliates or your involvement and participation therein, (B) in connection with any
investigation or review by the Company or any federal, state or local regulatory, quasi-regulatory or self-governing authority
(including, without limitation, the Securities and Exchange Commission) as any such investigation or review relates to events or
occurrences that transpired while you were a director of the Company and (C) with respect to transition and succession matters
(although you and the Company agree that any such transition and succession matters shall be concluded by the Resignation Date).
Your reasonable cooperation may include, but not be limited to (taking into account your personal and professional obligations,
including those to any new employer or entity to which you provide services), being available to meet and speak with officers or
employees of the Company and/or the Company’s counsel at reasonable times and locations, executing accurate and truthful documents
and taking such other actions as may reasonably be requested by the Company and/or the Company’s counsel to effectuate the foregoing.
You shall be entitled to reimbursement, upon receipt by the Company of suitable documentation, for reasonable and necessary travel
and other expenses (including the reasonable attorneys’ fees actually incurred in the event a conflict of interest between
you and the Company necessitates you retaining your own counsel in order to provide the cooperation hereunder) which you may incur
at the specific request of the Company and also any lost compensation due to fulfilling the obligations imposed by the Company
or its representatives in such matters and as approved by the Company in advance and in accordance with its policies and procedures
established from time to time.

 

     

     

    

 

8.   Mutual
Releases. You agree that, in consideration of this Agreement, you hereby waive, release and forever discharge any and all claims
and rights which you ever had, now have or may have against the Company and any of its subsidiaries or affiliated companies, and
their respective successors and assigns, current and former officers, agents, directors, representatives and employees, various
benefits committees, and their respective successors and assigns, heirs, executors and personal and legal representatives, based
on any act, event or omission occurring before you execute this Agreement arising out of, during or relating to your services with
the Company or the termination of such services, except as provided below. This waiver and release includes, but is not limited
to, any claims which could be asserted now or in the future, under: common law, including, but not limited to, breach of express
or implied duties, wrongful termination, defamation, or violation of public policy; any policies, practices, or procedures of the
Company; any federal or state statutes or regulations. Notwithstanding the foregoing, the Parties agree that you are not waiving
any claims or rights: (a) that may arise after the date on which you sign this Agreement, including the right to enforce this Agreement;
(b) that cannot be released as a matter of law; (c) to accrued, vested benefits under any benefit, stock, savings, insurance or
pension plan of the Company; and (d) to indemnification, advancement contribution or defense, which are expressly reserved as set
forth in Section 4 hereof.

 

The Company agrees that, in consideration
of this Agreement, the Company hereby waive, release and forever discharge any and all claims and rights which the Company ever
had, now have or may have against you, and your respective successors and assigns, and your respective successors and assigns,
heirs, executors and personal and legal representatives, based on any act, event or omission occurring before you execute this
Agreement arising out of, during or relating to your services with the Company or the termination of such services, except as provided
below. This waiver and release includes, but is not limited to, any claims which could be asserted now or in the future, under:
common law, including, but not limited to, breach of express or implied duties, wrongful termination, defamation, or violation
of public policy; any policies, practices, or procedures of the Company; any federal or state statutes or regulations.

 

(signature page follows)

 

    	 	2	 

     

    

 

IN
WITNESS WHEREOF, the Parties have executed this Agreement as of the date set forth below.

 

RELMADA THERAPEUTICS. INC.

 

	
        Signature:
	 	/s/ Sergio Traversa	 	Date: June 6, 2017  
	 	 	Sergio Traversa, CEO	 	 
	 	 	 	 	 
	
        

	 	/s/ Sandesh Seth	 	Date: June 6, 2017
	 	 	Sandesh Seth	 	 

 

    	 	3	 

     

    

 

ANNEX A

 

INDEMNIFICATION AGREEMENT

 

THIS INDEMNIFICATION AGREEMENT (this “Agreement”)
is made and entered into this 10th day of August, 2015, by and between Relmada Therapeutics, Inc., a Nevada corporation (the “Corporation”),
and Sandesh Seth (“Indemnitee”).

 

RECITALS

 

WHEREAS, the Corporation,
which is organized under the Nevada Revised Statutes (the “NRS”), wishes to enter into this Agreement to set
forth certain rights and obligations of the Indemnitee and the Corporation with respect to the Indemnitee’s service as a
director of the Corporation;

 

WHEREAS, it is essential
to the Corporation that it be able to retain and attract as directors and officers the most capable persons available;

 

WHEREAS, increased corporate
litigation has subjected directors and officers to litigation risks and expenses, and the limitations on the availability of directors
and officers liability insurance have made it difficult for the Corporation to attract and retain such persons;

 

WHEREAS, the Board of
Directors of the Corporation (the “Board”) has determined that the difficulty in attracting and retaining such
persons is detrimental to the best interests of the Corporation’s stockholders and that the Corporation should contractually
obligate itself to indemnify, and to advance expenses on behalf of, such persons to the fullest extent permitted by applicable
law so that they will serve the Corporation free from undue concern that they will not be so indemnified;

 

WHEREAS, Indemnitee
performs a valuable service to the Corporation in Indemnitee’s capacity as a director of the Corporation;

 

WHEREAS, the Corporation’s
Amended and Restated Bylaws (the “Bylaws”) include provisions providing for the indemnification of the directors
and officers of the Corporation, including persons serving at the request of the Corporation in such capacities with other corporations
or enterprises, as authorized by the NRS;

 

WHEREAS, the Corporation’s
Certificate of Incorporation (the “Charter”), the Bylaws and the NRS, by their nonexclusive nature, permit contracts
between the Corporation and its directors and officers with respect to indemnification of such persons;

 

WHEREAS, in recognition
of Indemnitee’s need for (a) substantial protection against personal liability as a condition to Indemnitee’s service
to the Corporation in Indemnitee’s capacity as a director of the Corporation in addition to Indemnitee’s reliance on
the Bylaws, which Indemnitee believes is inadequate in the present circumstances, and (b) specific contractual assurance of Indemnitee’s
rights to full indemnification against risks and expenses (regardless of, among other things, any amendment to or revocation of
the Charter and/or the Bylaws, any change in the composition of the Corporation’s Board, or a change in control of the Corporation);

 

    	 	4	 

     

    

 

WHEREAS, the Corporation
intends that this Agreement provide Indemnitee with greater protection than that which is provided by the Bylaws; and

 

WHEREAS, in order
to induce Indemnitee to serve as a director of the Corporation, the Corporation has determined and agreed to enter into this Agreement
with Indemnitee.

 

NOW, THEREFORE, in
consideration of Indemnitee’s service as a director of the Corporation following the date hereof, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Corporation and Indemnitee hereby agree
as follows:

 

1.       Indemnity
of Indemnitee. The Corporation agrees to hold harmless and indemnify Indemnitee to the fullest extent authorized or permitted
by law, the provisions of the Charter, and the Bylaws, as the same may be amended from time to time (but, only to the extent that
such amendment permits the Corporation to provide broader indemnification rights than such law, the Charter, or the Bylaws permitted
prior to adoption of such amendment). For purposes of this Agreement, the meaning of the phrase “to the fullest extent authorized
or permitted by law” shall include, but not be limited to: (i) to the fullest extent authorized or permitted by the provision
of the NRS that authorizes or contemplates additional indemnification by agreement, or the corresponding provision of any amendment
to or replacement of the NRS or such provision thereof; and (ii) to the fullest extent authorized or permitted by any amendments
to or replacements of the NRS adopted after the date of this Agreement that increase the extent to which a corporation may indemnify
its directors and officers.

 

2.       Additional
Indemnity. In addition to and not in limitation of the indemnification otherwise provided for herein, and subject only to the
exclusions set forth in Section 3 hereof, the Corporation further agrees to hold harmless and indemnify Indemnitee:

 

(a)       against
any and all (i) expenses (including attorneys’ fees), retainers, court costs, transcript costs, fees of experts, witness
fees, travel expenses, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees and all
other disbursements or expenses of the types customarily incurred in connection with prosecuting, defending, preparing to prosecute
or defend, investigating, participating, or being or preparing to be a witness in any threatened, pending or completed action,
suit, arbitration, alternate dispute resolution mechanism, investigation, inquiry, administrative hearing or any other actual,
threatened or completed proceeding, including any appeal thereof or related thereto (each, a “Proceeding”),
or responding to, or objecting to, a request to provide discovery in any Proceeding, (ii) damages, judgments, fines and amounts
paid in settlement and any other amounts that Indemnitee becomes legally obligated to pay (including any federal, state or local
taxes imposed on Indemnitee as a result of receipt of reimbursements or advances of expenses under this Agreement) and (iii) the
premium, security for, and other costs relating to any costs bond, supersedes bond, or other appeal bond or its equivalent, whether
civil, criminal, arbitrational, administrative or investigative with respect to any Proceeding (items under clauses, (i), (ii)
and (iii), collectively, the “Expenses”) actually and reasonably incurred by Indemnitee, or on Indemnitee’s
behalf, because of any claim or claims made against or by him in connection with any Proceeding, whether formal or informal (including
an action by or in the right of the Corporation), to which Indemnitee is, was or at any time becomes a party or a witness, or
is threatened to be made a party to, a participant in or a witness with respect to, by reason of the fact that Indemnitee is,
was or at any time becomes a director or officer of the Corporation, or is or was serving or at any time serves at the request
of the Corporation as a director or officer of another corporation, partnership, joint venture, trust or other enterprise (“Corporate
Status”);

 

    	 	5	 

     

    

 

(b)       against
any and all Expenses actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf, if Indemnitee is, or is threatened
to be made, a party to or a participant in any Proceeding by or in the right of the Corporation to procure a judgment in its favor;

 

(c)       against
any and all Expenses actually and reasonably incurred by Indemnitee, or on Indemnitee’s behalf, if Indemnitee is, by reason
of his or her Corporate Status, a witness in any Proceeding to which Indemnitee is not a party and is not threatened to be made
a party; and

 

(d)       otherwise
to the fullest extent as may be provided to Indemnitee by the Corporation under the non-exclusivity provisions of the NRS, the Charter
and the Bylaws.

 

3.       Limitations
on Additional Indemnity. No indemnity pursuant to Section 2 hereof shall be paid by the Corporation:

 

(a)       on
account of any claim or Proceeding against Indemnitee for an accounting of profits made from the purchase or sale by Indemnitee
of securities of the Corporation pursuant to the provisions of Section 16(b) of the Securities Exchange Act of 1934, as heretofore
or hereafter amended (the “Exchange Act”), or similar provisions of any federal, state or local law if the final,
non-appealable judgment of a court of competent jurisdiction finds Indemnitee to be liable for disgorgement under Section 16(b)
of the Exchange Act;

 

(b)       on
account of Indemnitee’s conduct that is established by a final, non-appealable judgment of a court of competent jurisdiction
as knowingly fraudulent or deliberately dishonest or that constituted willful misconduct;

 

(c)       for
which payment is actually made to Indemnitee under (i) a valid and collectible insurance policy, including under any policy of
insurance purchased and maintained on Indemnitee’s behalf by the Corporation or (ii) under a valid and enforceable indemnity
clause, bylaw, or agreement, including, but not limited to, an indemnity clause, bylaw, or agreement relating to another corporation,
partnership, joint venture, trust, or other enterprise for which Indemnitee is or was serving as a director or officer at the request
of the Corporation; provided, that indemnity pursuant to Section 2 hereof shall be paid by the Corporation in respect
of any excess beyond payment actually received by Indemnitee under such insurance policy, clause, bylaw or agreement;

 

(d)       if
and to the extent indemnification is contrary to law, either as a matter of public policy, or under the provisions of the Federal
Securities Act of 1933, as amended, the Securities Exchange Act of 1934, as amended, the NRS, or any other applicable law; or

 

    	 	6	 

     

    

 

(e)       in
connection with any Proceeding (or part thereof) initiated by Indemnitee, against the Corporation or its directors, officers, employees
or other agents, unless (i) such indemnification is expressly required to be made by law, (ii) the Corporation has joined in the
Proceeding (or relevant part thereof), (iii) the Board has consented to the initiation of such Proceeding, (iv) such indemnification
is provided by the Corporation, in its sole discretion, pursuant to the powers vested in the Corporation under the NRS, or (v)
the Proceeding (or relevant part thereof) is initiated pursuant to Section 12 hereof.

 

4.       Continuation
of Indemnity. All agreements and obligations of the Corporation contained herein shall continue during the period Indemnitee
is a director or officer of the Corporation (or is or was serving at the request of the Corporation as a director or officer of
another corporation, partnership, joint venture, trust or other enterprise) and shall continue thereafter so long as Indemnitee
shall be subject to any possible claim or threatened, pending or completed Proceeding, whether civil, criminal, arbitrational,
administrative or investigative, including any appeal thereof or relating thereto, in respect of which Indemnitee is granted rights
of indemnification or advancement of Expenses hereunder, in each case, by reason of the fact of the Indemnitee’s Corporate
Status.

 

5.       Partial
Indemnification. Indemnitee shall be entitled under this Agreement to indemnification by the Corporation for a portion of the
Expenses, judgments, fines and amounts paid in settlement and any other amounts that Indemnitee becomes legally obligated to pay
in connection with any Proceeding referred to in Section 2 hereof even if not entitled hereunder to indemnification for
the total amount thereof, and the Corporation shall indemnify Indemnitee for the portion thereof to which Indemnitee is entitled.

 

6.       Notification
and Defense of Claim. To obtain indemnification under this Agreement, Indemnitee shall submit to the Corporation a written
request therefor. As soon as practicable, and in any event, not later than thirty (30) days after Indemnitee becomes aware, by
written or other overt communication, of any pending or threatened litigation, claim or assessment, Indemnitee will, if a claim
for indemnification in respect thereof is to be made against the Corporation under this Agreement, notify the Corporation of such
pending or threatened litigation, claim or assessment; but the omission so to notify the Corporation will not relieve the Corporation
from any liability which it may have to Indemnitee otherwise under this Agreement, and any delay in so notifying the Corporation
shall not constitute a waiver by Indemnitee of any of Indemnitee’s rights under this Agreement. With respect to any such
pending or threatened litigation, claim or assessment as to which Indemnitee notifies the Corporation of the commencement thereof:

 

(a)       the
Corporation will be entitled to participate therein at its own expense;

 

(b)       except
as otherwise provided below, the Corporation may, at its option and jointly with any other indemnifying party similarly notified
and electing to assume such defense, assume the defense thereof, with counsel reasonably satisfactory to Indemnitee. After notice
from the Corporation to Indemnitee of its election to assume the defense thereof, the Corporation will not be liable to Indemnitee
under this Agreement for any legal or other expenses subsequently incurred by Indemnitee in connection with the defense thereof
except for reasonable costs of investigation or otherwise as provided below. Indemnitee shall have the right to employ separate
counsel in such Proceeding but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption
of the defense thereof shall be at the expense of Indemnitee unless (i) the employment of counsel by Indemnitee has been authorized
by the Corporation, (ii) Indemnitee shall have reasonably concluded, and so notified the Corporation, that there may be a conflict
of interest between the Corporation and Indemnitee in the conduct of the defense of such action, or (iii) the Corporation shall
not in fact have employed counsel to assume the defense of Indemnitee in connection with such action; in any of such cases the
fees and expenses of Indemnitee’s separate counsel shall be at the expense of the Corporation. The Corporation shall not
be entitled to assume the defense of any Proceeding brought by or on behalf of the Corporation or as to which Indemnitee shall
have made the conclusion provided for in clause (ii) above; and

 

    	 	7	 

     

    

 

(c)       the
Corporation shall not be liable to indemnify Indemnitee under this Agreement for any amounts paid in settlement of any action or
claim effected without the Corporation’s written consent, which consent shall not be unreasonably withheld, conditioned or
delayed. The Corporation shall not enter into any settlement in connection with a Proceeding in any manner which would impose any
Expenses, penalties (whether civil or criminal) or limitations on Indemnitee without Indemnitee’s written consent, which
may be given or withheld in Indemnitee’s sole and reasonable discretion.

 

7.       Expenses.
The Corporation shall advance, to the extent not prohibited by law, all Expenses actually and reasonably incurred by Indemnitee
in connection with any Proceeding promptly following request therefor, but in any event no later than twenty (20) days after the
receipt by the Corporation of a written statement or statements requesting such advances (which shall include invoices received
by Indemnitee in connection with such Expenses but, in the case of invoices in connection with legal services, any references to
legal work performed or to expenditure made that would cause Indemnitee to waive any privilege accorded by applicable law shall
not be included with the invoice) from time to time, whether prior to or after the final disposition of any Proceeding. The right
to advancement described in this Section 7 is vested. Advances shall be unsecured and interest free. Advances shall be made
without regard to Indemnitee’s ability to repay the expenses and without regard to Indemnitee’s ultimate entitlement
to indemnification under the other provisions of this Agreement. The execution and delivery to the Corporation of this Agreement
shall constitute an undertaking by Indemnitee to the fullest extent required by law to repay all advances if and to the extent
that it is ultimately determined by a court of competent jurisdiction in a final, non-appealable judgment that Indemnitee is not
entitled to be indemnified by the Corporation, and Indemnitee shall qualify for advances immediately upon such execution and delivery.
The right to advances under this Section 7 shall in all events continue until final disposition of any Proceeding, including
any appeal therein.

 

8.       Contribution.

 

(a)       Whether
or not the indemnification provided in Section 2 is available, in respect of any Proceeding in which the Corporation is
jointly liable with Indemnitee (or would be if joined in such Proceeding), the Corporation shall pay, in the first instance, the
entire amount of any judgment or settlement of such Proceeding without requiring Indemnitee to contribute to such payment and the
Corporation hereby waives and relinquishes any right of contribution it may have against Indemnitee. The Corporation shall not
enter into any settlement of any Proceeding in which the Corporation is jointly liable with Indemnitee (or would be if joined in
such Proceeding) unless such settlement provides for a full and final release of all claims asserted against Indemnitee.

 

    	 	8	 

     

    

 

(b)       Without
diminishing or impairing the obligations of the Corporation set forth in Section 8(a), if, for any reason, Indemnitee shall
elect or be required to pay all or any portion of any judgment or settlement in any threatened, pending or completed Proceeding
in which the Corporation is jointly liable with Indemnitee (or would be if joined in such Proceeding), the Corporation shall contribute
to the amount of Expenses, judgments, fines and amounts paid in settlement actually and reasonably incurred and paid or payable
by Indemnitee in proportion to the relative benefits received by the Corporation and all officers, directors or employees of the
Corporation, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one
hand, and Indemnitee, on the other hand, from the transaction from which such Proceeding arose; provided, however,
that the proportion determined on the basis of relative benefit may, to the extent necessary to conform to law, be further adjusted
by reference to the relative fault of the Corporation and all officers, directors or employees of the Corporation other than Indemnitee
who are jointly liable with Indemnitee (or would be if joined in such Proceeding), on the one hand, and Indemnitee, on the other
hand, in connection with the events that resulted in such expenses, judgments, fines or settlement amounts, as well as any other
equitable considerations which the law may require to be considered. The relative fault of the Corporation and all officers, directors
or employees of the Corporation, other than Indemnitee, who are jointly liable with Indemnitee (or would be if joined in such Proceeding),
on the one hand, and Indemnitee, on the other hand, shall be determined by reference to, among other things, the degree to which
their actions were motivated by intent to gain personal profit or advantage, the degree to which their liability is primary or
secondary and the degree to which their conduct is active or passive.

 

(c)       The
Corporation hereby agrees to fully indemnify and hold Indemnitee harmless from any claims of contribution which may be brought
by officers, directors or employees of the Corporation, other than Indemnitee, who may be jointly liable with Indemnitee.

 

(d)       To
the fullest extent permissible under applicable law, if the indemnification provided for in this Agreement is unavailable
to Indemnitee for any reason whatsoever, the Corporation, in lieu of indemnifying Indemnitee, shall contribute to the amount actually
and reasonably incurred by Indemnitee, whether for judgments, fines, penalties, excise taxes, amounts paid or to be paid in settlement
and/or for Expenses, in connection with any claim relating to an indemnifiable event under this Agreement, in such proportion
as is deemed fair and reasonable in light of all of the circumstances of such Proceeding in order to reflect (i) the relative
benefits received by the Corporation and Indemnitee as a result of the event(s) and/or transaction(s) giving cause to such Proceeding;
and/or (ii) the relative fault of the Corporation (and its directors, officers, employees and agents) and Indemnitee in connection
with such event(s) and/or transaction(s).

 

9.       Presumptions
and Effect of Certain Proceedings.

 

(a)       In
making a determination with respect to Indemnitee’s entitlement to indemnification hereunder, the person, persons or entity
making such determination shall, to the fullest extent not prohibited by law, presume that Indemnitee is entitled to indemnification
under this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section 6 hereof. If the
Corporation contests any claim or assertion that Indemnitee is entitled to indemnification hereunder, the Corporation shall, to
the fullest extent not prohibited by law, have the burden of proof to overcome such presumption in connection with the making by
such person, persons, or entity of any determination with respect to Indemnitee’s entitlement to indemnification.

 

    	 	9	 

     

    

 

(b)       Without
limiting the foregoing, if any Proceeding is disposed of on the merits or otherwise (including a disposition without prejudice),
without (i) the final disposition being adverse to Indemnitee, (ii) a final adjudication by a court of competent jurisdiction that
Indemnitee was liable to the Corporation, (iii) a plea of guilty (iv) a final adjudication by a court of competent jurisdiction
that Indemnitee did not act in good faith, and in a manner Indemnitee reasonably believed to be in or not opposed to the best interests
of the Corporation, or (v) with respect to any criminal proceeding, a final adjudication by a court of competent jurisdiction that
Indemnitee had reasonable cause to believe Indemnitee’s conduct was unlawful, Indemnitee shall be considered for the purposes
hereof to have been wholly successful with respect thereto.

 

(c)       The
termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a
plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in this Agreement) of itself adversely
affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner
which he or she reasonably believed to be in or not opposed to the best interests of the Corporation or, with respect to any criminal
Proceeding, that Indemnitee had reasonable cause to believe that such Indemnitee’s conduct was unlawful.

 

(d)       For
purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith to the extent Indemnitee relied
in good faith on (i) the records or books of account of the Corporation, including financial statements , (ii) information supplied
to Indemnitee by the officers of the Corporation in the course of their duties, (iii) the advice of legal counsel for the Corporation
or its Board or counsel selected by any committee of the Board or (iv ) information or records given or reports made to the Corporation
by an independent certified public accountant, an appraiser, investment banker or other expert selected with reasonable care by
the Corporation or its Board or any committee of the Board.

 

10.       Information
Sharing. To the extent that the Corporation receives a request or requests from a governmental third party or other licensing
or regulating organization (the “Requesting Agency”), whether formal or informal, to produce documentation or
other information concerning an investigation, whether formal or informal, being conducted by the Requesting Agency, and such investigation
is reasonably likely to include review of any actions or failures to act by Indemnitee, the Corporation shall promptly give notice
to Indemnitee of said request or requests and any subsequent request. In addition, the Corporation shall provide Indemnitee with
a copy of any and all information or documentation that the Corporation shall provide to the Requesting Agency.

 

11.       No
Imputation. The knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Corporation
or the Corporation itself shall not be imputed to Indemnitee for purposes of determining any rights under this Agreement.

 

    	 	10	 

     

    

 

12.       Enforcement.

 

(a)       Any
right to indemnification or advances granted by this Agreement to Indemnitee shall be enforceable by or on behalf of Indemnitee
in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, (ii) no
disposition of such claim is made within ninety (90) days of request therefor; (iii) advancement of Expenses is not timely
made pursuant to Section 7, (iv) payment of indemnification pursuant to this Agreement is not made within ten (10) days
after a determination has been made that Indemnitee is entitled to indemnification, or (v) the Corporation or any other person
or entity takes or threatens to take any action to declare this Agreement void or unenforceable, or institutes any litigation or
other action or proceeding designed to deny, or to recover from, Indemnitee the benefits provided or intended to be provided to
Indemnitee hereunder, Indemnitee shall be entitled to an adjudication by the Delaware Court of Chancery of Indemnitee’s entitlement
to such indemnification or advancement of Expenses, and the Corporation shall not oppose Indemnitee’s right to seek any such
adjudication in accordance with this Agreement. Indemnitee, in such enforcement action, if successful in whole or in part, shall
be entitled to be paid also the Expenses of prosecuting Indemnitee’s claim. It shall be a defense to any action for which
a claim for indemnification is made under Section 2 hereof (other than an action brought to enforce a claim for advance
or reimbursement of Expenses under this Agreement, provided that the required undertaking has been tendered to the Corporation)
that Indemnitee is not entitled to indemnification because of the limitations set forth in Section 3 hereof. Neither the
failure of the Corporation (including the Board, any committee of the Board, or the Corporation’s its stockholders, or any
subgroup of such directors or stockholders) to have made a determination prior to the commencement of such enforcement action that
indemnification of Indemnitee is proper in the circumstances, nor an actual determination by the Corporation (including the Board,
any committee of the Board, or the Corporation’s stockholders, or any subgroup of such directors or stockholders) that such
indemnification is improper shall be a defense to the action or create a presumption that Indemnitee is not entitled to indemnification
under this Agreement or otherwise.

 

(b)       To
the fullest extend not prohibited by law, the Corporation shall be precluded from asserting in any judicial proceeding commenced
pursuant to this Section 12 that the procedures and presumptions of this Agreement are not valid, binding and enforceable
and shall stipulate in any such court that the Corporation is bound by all the provisions of this Agreement. If a determination
shall have been made pursuant to this Agreement that Indemnitee is entitled to indemnification, the Corporation shall be bound
by such determination in any Proceeding commenced pursuant to this Section 12, absent (i) a misstatement by Indemnitee of
a material fact, or an omission of a material fact necessary to make Indemnitee’s statements not materially misleading, in
connection with the request for indemnification, or (ii) a prohibition of such indemnification under applicable law.

 

13.       Subrogation.
In the event of payment under this Agreement, the Corporation shall be subrogated to the extent of such payment to all of the rights
of recovery of Indemnitee, who shall execute all documents required and shall do all acts that may be necessary to secure such
rights and to enable the Corporation effectively to bring suit to enforce such rights.

 

    	 	11	 

     

    

 

14.       Non-Exclusivity
of Rights. The rights conferred on Indemnitee by this Agreement shall not be exclusive of any other right which Indemnitee
may have or hereafter acquire under any statute, provision of the Charter or Bylaws, agreement, vote of stockholders or directors,
or otherwise, both as to action in Indemnitee’s official capacity and as to action in another capacity while holding office.
To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification or advancement
of Expenses than would be afforded currently under the Charter or Bylaws and this Agreement, it is the intent of the parties hereto
that Indemnitee shall enjoy by this Agreement the greater benefits so afforded by such change, subject to the restrictions expressly
set forth herein or therein. Except as expressly set forth herein, no right or remedy herein conferred is intended to be exclusive
of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy
given hereunder or now or hereafter existing at law or in equity or otherwise. Except as expressly set forth herein, the assertion
or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other
right or remedy.

 

15.       Insurance.
To the extent that the Corporation maintains an insurance policy or policies providing liability insurance for directors, trustees,
general partners, managing members, officers, employees, agents or fiduciaries of the Corporation, Indemnitee shall be covered
by such policy or policies (including with respect to prior service) to the same extent as the most favorably-insured persons under
such policy or policies in a comparable position.

 

16.       Enforcement;
Survival of Rights.

 

(a)       The
Corporation expressly confirms and agrees that the Corporation has entered into this Agreement and assumed the obligations imposed
on it hereby in order to induce Indemnitee to serve as a director of the Corporation, and the Corporation acknowledges that Indemnitee
is relying upon this Agreement in serving the Corporation in such capacity.

 

(b)       The
rights conferred on Indemnitee by this Agreement shall continue after Indemnitee has ceased to be a director or officer of the
Corporation or to serve at the request of the Corporation as a director or officer agent of another corporation, partnership, joint
venture, trust or other enterprise, and shall inure to the benefit of Indemnitee’s heirs, executors and administrators.

 

(c)       The
Corporation shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to all or
substantially all of the business or assets of the Corporation, expressly to assume and agree to perform this Agreement in the
same manner and to the same extent that the Corporation would be required to perform if no such succession had taken place.

 

(d)       The
Corporation and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate,
impracticable and difficult of proof, and further agree that such breach may cause Indemnitee and the Corporation irreparable harm.
Accordingly, the parties hereto agree that each of the Corporation and the Indemnitee may enforce this Agreement by seeking injunctive
relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable harm and that by seeking
injunctive relief and/or specific performance, they shall not be precluded from seeking or obtaining any other relief to which
they may be entitled. The Corporation and Indemnitee further agree that they shall be entitled to such specific performance and
injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without the necessity
of posting bonds or other undertaking in connection therewith. The Corporation and Indemnitee acknowledge that in the absence of
a waiver, a bond or undertaking may be required by the Delaware Court of Chancery, and they hereby waive any such requirement of
such a bond or undertaking.

 

    	 	12	 

     

    

 

17.       No
Conflicts.To the extent that any provision of this Agreement conflicts with the Charter, the Bylaws, or applicable law,
the Charter, the Bylaws, or such applicable law (as applicable) shall govern.

 

18.       Separability.
Each of the provisions of this Agreement is a separate and distinct agreement and independent of the others, so that if any provision
hereof shall be held to be invalid, illegal or unenforceable for any reason, (i) such invalidity, illegality or unenforceability
shall not affect the validity, legality or enforceability of the remaining provisions of this Agreement (including without limitation,
each portion of any Section of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that
is not itself invalid, illegal or unenforceable) and such other provisions shall remain enforceable to the fullest extent permitted
by law; (ii) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and to
give the maximum effect to the intent of the parties hereto; and (iii) to the fullest extent possible, the provisions of this Agreement
(including, without limitation, each portion of any section of this Agreement containing any such provision held to be invalid,
illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the
intent manifested thereby. Furthermore, if this Agreement shall be invalidated in its entirety on any ground, then the Corporation
shall nevertheless indemnify Indemnitee to the fullest extent provided by the Charter (if applicable), the Bylaws, the NRS or any
other applicable law.

 

19.       Governing
Law. This Agreement shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware,
without regard to its principles of conflicts of laws. The Corporation and Indemnitee hereby irrevocably and unconditionally (i)
agree that any action or proceeding arising out of or in connection with this Agreement may be brought in the Delaware Court of
Chancery, (ii) consent to submit to the jurisdiction of the Delaware Court of Chancery for purposes of any action or proceeding
arising out of or in connection with this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding
in the Delaware Court of Chancery, and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding
brought in the Delaware Court of Chancery has been brought in an improper or inconvenient forum.

 

20.       Amendment
and Termination. No amendment, modification, termination or cancellation of this Agreement shall be effective unless in writing
signed by both parties hereto.

 

21.       Identical
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to
be an original but all of which together shall constitute but one and the same Agreement. Only one such counterpart need be produced
to evidence the existence of this Agreement.

 

    	 	13	 

     

    

 

22.       Notices.
All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly given
(i) upon delivery if delivered by hand to the party to whom such communication was directed or (ii) upon the third business day
after the date on which such communication was mailed if mailed by certified or registered mail with postage prepaid:

 

(a)       If
to Indemnitee, at the address indicated on the signature page hereof.

 

(b)       If
to the Corporation, to:

 

Relmada Therapeutics, Inc.

 

275 Madison Avenue, Suite 702

 

New York, NY 10016

Attention:Chief Executive
Officer

 

or to such other address as
may have been furnished to Indemnitee by the Corporation.

 

22.       Headings.
The headings of the sections of this Agreement are inserted for convenience only and shall not be deemed to constitute part of
this Agreement or to affect the construction hereof.

 

[Remainder of Page Intentionally Left
Blank]

 

    	 	14	 

     

    

 

IN WITNESS WHEREOF,
the parties hereto have executed this Indemnification Agreement on and as of the day and year first above written.

 

	 	COMPANY:
	 	 
	 	RELMADA THERAPEUTICS, INC.
	 	 
	 	By:	/s/ Sergio Traversa
	 	Name: 	Sergio Traversa
	 	Title:   	Chief Executive Officer
	 	 
	 	INDEMNITEE:
	 	 
	 	Sandesh Seth
	 	Sandesh Seth

 

    	 	15	 

     

    

 

Other Agreements and Documents

 

		§	Advisory and Consulting Agreement, dated
August 4, 2015, between you and the Company.

 

		§	Strategic Advisory and Consulting Agreements,
dated December 6, 2011 and October 17, 2012, between the Company and Jamess Capital Group LLC (“Jamess”).

 

		§	Termination Agreement, dated August 3, 2015,
between the Company and Jamess.

 

		§	Engagement agreements entered into by and
between the Company and Laidlaw & Company (UK) Ltd. (“Laidlaw”), dated December 6, 2011, April 18, 2012, February
25, 2013, October 24, 2013, February 18, 2014 and May 19, 2014.

 

		§	Company’s Articles of Incorporation and Bylaws.

 

 

16Exhibit 10.25

 

Relmada Therapeutics, Inc.

Confidential

 

CONSULTING AGREEMENT

This Consulting Agreement (“Agreement”)
is entered into on June 12, 2017 (the “Effective Date”) by and between Relmada Therapeutics, Inc.,
a Nevada corporation with a business address at 275 Madison Avenue, Suite 702, New York, NY 10016, U.S.A. (“Relmada”
or the “Company”), and Maged Shenouda (“Consultant”).

 

WHEREAS, Relmada desires that Consultant
provide consulting services to assist Relmada with financial matters, the development of the Company’s products, and other
matters that be requested by the Company (collectively referred to as the “Services”).

 

WHEREAS, Consultant has the requisite
knowledge and experience to provide the Services;

 

NOW, THEREFORE, Relmada and Consultant
agree as follows:

 

		1.	Activities. The Services shall be conducted according to the scope set forth herein.

 

		2.	Project Materials and Consultant Services.

 

		2.1	Relmada will from time to time provide Consultant with access to product information and documents,
as well as reports and experimental data and other information, so as to enable Consultant to provide the Services.

 

		2.2	Consultant agrees to communicate to Relmada, its designees, successors, legal representatives or
assigns, any facts or other information known to Consultant relating to the Services.

 

		3.	Reasonable
Efforts. Consultant agrees to use all reasonable efforts to provide the Services required under this Agreement within
a reasonable time period.  Consultant shall perform Services conscientiously and in a professional manner, and devote his
best efforts and abilities thereto. Consultant shall observe all policies and procedures of the Company, and such other directives
as may be promulgated from time to time by the Company’s officers or board of directors.

 

4.       Payments
and Expenses

 

		4.1.	Service Fee. In consideration of the Services to be performed under this Agreement,
Relmada shall provide compensation to Consultant for his activities hereunder in the amount of Ten Thousand dollars per month
 (US $10,000/month) (“Service Fee”).

 

		4.2.	Expenses. In addition to the Service Fee referenced in paragraph 4.1 above, Relmada
will reimburse Consultant for reasonable and customary travel, lodging and out-of-pocket expenses incurred, in each case at Relmada’s
written request, in connection with the performance of the Services, and in accordance with the terms and conditions set forth
herein. For up to $2,500, Relmada will not be liable for payment of any travel, lodging or out-of-pocket expenses incurred by Consultant
without the prior written authorization of Relmada.

 

    	Relmada-Consulting Agreement
	Page
                                         1
                                         of 4	 

     

    

 

Relmada Therapeutics, Inc.

Confidential

 

		5.	Independent Contractor.  Consultant’s
relationship to Relmada under this Agreement shall be that of an independent contractor and not an agent, joint venturer,
or partner of Relmada. Consultant will be responsible for all applicable federal, state and local withholding taxes and
unemployment taxes, as well as social security, state disability insurance, workers’ compensation and all other payroll
charges payable to, or on behalf of, Consultant.

 

		6.	Effective Date and Term.
The initial term of this Agreement shall begin on the Effective Date and shall continue for one year (1) thereafter unless earlier
terminated pursuant to Section 7.

 

		7.	Termination.
                                         The Company and Consultant each shall have the right to terminate this Agreement
                                         upon 15 days prior written notice to the party. 

 

		8.	Data and Reporting. All written materials, comments, critiques, conclusions, data,
analyses, models, graphs, equations, statistical methodologies and other relevant information generated or utilized by Consultant
during and pursuant to performing the Services will be promptly and fully disclosed to Relmada, and shall be freely usable in all
respects by Relmada consistent with good business judgment and in Relmada’s sole discretion. Subject to the provisions of
Paragraph 9 below, Consultant shall be free to maintain a single archival copy of all materials generated by Consultant and related
to the Services.

 

		9.	Confidential Information.

 

		9.1	“Confidential Information” means all information provided by or on behalf of Relmada
to Consultant or generated by Consultant during and pursuant to performing the Services hereunder, whether in written or oral form.

 

		9.2	Consultant shall use the Confidential Information solely for the purpose of performing the Services
pursuant to this Agreement. Consultant shall keep all Confidential Information in confidence, and shall not disclose the Confidential
Information to anyone. Consultant shall not disclose any Confidential
Information (including through lecture, presentation, manuscript, abstract, poster or any other publication) without prior written
authorization from Relmada. This provision shall remain in effect for five (5) years following the termination of this Agreement.

 

    	Relmada-Consulting Agreement
	Page
                                         2
                                         of 4	 

     

    

 

Relmada Therapeutics, Inc.

Confidential

 

		9.3	Specifically excepted from the definition of Confidential Information is all information that:

 

		a)	is already known by Consultant at the time of disclosure by Relmada as demonstrated by prior written
records, and that is not the subject of a separate confidentiality agreement between Relmada and Consultant; or

 

		b)	is already available or becomes available in print or other tangible form to the public through
no fault of the Consultant;

 

		c)	is received by the Consultant from a third party who has the right to disclose it, and who did
not receive it, directly or indirectly, from Relmada; or

 

		d)	is independently developed by Consultant without use of, reference to or reliance on in any manner
whatsoever the Confidential Information or any information that is the subject of a separate confidentiality agreement between
Relmada and Consultant.

 

		10.	Intentionally left blank.

 

		11.	Indemnification. Company shall indemnify the Consultant for all costs, fees (including
reasonable attorney’s fees), expenses, losses and other damages arising from this Agreement. The
Company agrees that you will also be entitled to any and all rights to contribution, advancement of expenses, defense or indemnification
you may have under the Indemnification Agreement between you and the Company as a director, and the indemnification provisions
of Company bylaws. 

 

		12.	Modification. Any alteration, modification, or amendment to this Agreement must be
in writing and signed by both parties.

 

		13.	Applicable Law. This Agreement will in all respects be governed by, and interpreted,
construed and enforced in accordance with, the laws of the State of New York. The parties further agree that any action or
proceeding arising out of or in connection with this Agreement will be venued in a federal or state court of appropriate venue
and subject matter jurisdiction located in the State of New York. Each party hereto irrevocably consents to the personal jurisdiction
of the courts in the State of New York.

 

		14.	Waiver. No waiver of any term, provision or condition of this Agreement, whether
by conduct or otherwise in any one or more instances, shall be deemed to be, or be construed as, a further or continuing waiver
of any such term, provision, or condition, or of any other term, provision or condition of this Agreement.

 

		15.	Entire Agreement. This Agreement, together
with all Exhibits, constitutes the entire agreement between the parties with respect to the subject matter contained herein.
This Agreement supersedes all prior understandings and agreements between the parties with respect to the subject matter
contained herein. This Agreement and the rights and obligations set forth herein may not be modified, amended or waived, whether
in whole or in part, except by a writing signed by both parties. This Agreement does not supersede any rights or other agreements
that Consultant may have as a Board member.

 

    	Relmada-Consulting Agreement
	Page
                                         3
                                         of 4	 

     

    

 

Relmada Therapeutics, Inc.

Confidential

 

WHEREFORE, the parties hereto
place their hands and seals:

 

	Maged shenouda	 	RELMADA THERAPEUTICS, INC.
	 	 	 
	/s/ Maged Shenouda     	 	By:	/s/ Sergio Traversa
	 	 	 	CEO
		 	 	 
	Date Executed: June 12, 2017   	 	 	Date Executed: June 12, 2017

 

 

	Relmada-ConsultingAgreement	Page 4 of 4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00275-of-00352.parquet"}]]